188 related articles for article (PubMed ID: 35280672)
1. Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21/CCR7 axis.
Zhang L; Zhu L; Yao X; Lou X; Wan J; Duan X; Pan L; Li A; Gu Z; Wang M; Wang F; Qin Z
Int J Biol Sci; 2022; 18(4):1476-1490. PubMed ID: 35280672
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells through the CCR7-CCL21 Axis Modulated by TNF-α.
Zhang S; Wang H; Xu Z; Bai Y; Xu L
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33158173
[TBL] [Abstract][Full Text] [Related]
3. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
4. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
[TBL] [Abstract][Full Text] [Related]
5. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
Tutunea-Fatan E; Majumder M; Xin X; Lala PK
Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
[TBL] [Abstract][Full Text] [Related]
6. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
Takeuchi H; Fujimoto A; Tanaka M; Yamano T; Hsueh E; Hoon DS
Clin Cancer Res; 2004 Apr; 10(7):2351-8. PubMed ID: 15073111
[TBL] [Abstract][Full Text] [Related]
7. [Progress in targeting therapy of cancer metastasis by CCL21/CCR7 axis].
Zhang L; Wang F; Yao X; Ma S; Zhang L; Qin Z
Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2741-2754. PubMed ID: 33398969
[TBL] [Abstract][Full Text] [Related]
8. MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma.
Liu YX; Bai JX; Li T; Fu XQ; Chen YJ; Zhu PL; Chou JY; Yin CL; Li JK; Wang YP; Wu JY; Yu ZL
Phytomedicine; 2019 Nov; 64():153084. PubMed ID: 31514083
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.
Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J
Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
[TBL] [Abstract][Full Text] [Related]
11. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Polyplex on CCR7 Down-Regulation and T Cell Elevation for Lymphatic Metastasis Blocking on Breast Cancer.
Deng Y; Tan C; Huang S; Sun H; Li Z; Li J; Zhou Z; Sun M
Adv Healthc Mater; 2022 Nov; 11(22):e2201166. PubMed ID: 36113849
[TBL] [Abstract][Full Text] [Related]
13. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.
Wiley HE; Gonzalez EB; Maki W; Wu MT; Hwang ST
J Natl Cancer Inst; 2001 Nov; 93(21):1638-43. PubMed ID: 11698568
[TBL] [Abstract][Full Text] [Related]
14. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
Han L; Zhang L
Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
[TBL] [Abstract][Full Text] [Related]
15. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
16. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
[TBL] [Abstract][Full Text] [Related]
17. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection.
An S; Tiruthani K; Wang Y; Xu L; Hu M; Li J; Song W; Jiang H; Sun J; Liu R; Huang L
Small; 2019 Mar; 15(9):e1805182. PubMed ID: 30690891
[TBL] [Abstract][Full Text] [Related]
18. β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet-induced obese C57BL/6N mice.
Jung JI; Kim EJ; Kwon GT; Jung YJ; Park T; Kim Y; Yu R; Choi MS; Chun HS; Kwon SH; Her S; Lee KW; Park JH
Carcinogenesis; 2015 Sep; 36(9):1028-39. PubMed ID: 26025912
[TBL] [Abstract][Full Text] [Related]
19. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
Hauser MA; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.
Maolake A; Izumi K; Natsagdorj A; Iwamoto H; Kadomoto S; Makino T; Naito R; Shigehara K; Kadono Y; Hiratsuka K; Wufuer G; Nastiuk KL; Mizokami A
Cancer Sci; 2018 May; 109(5):1524-1531. PubMed ID: 29575464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
